Key Insights

Highlights

Success Rate

95% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

2.9%

1 terminated out of 34 trials

Success Rate

95.2%

+8.7% vs benchmark

Late-Stage Pipeline

9%

3 trials in Phase 3/4

Results Transparency

20%

4 of 20 completed with results

Key Signals

4 with results95% success

Data Visualizations

Phase Distribution

23Total
Not Applicable (10)
P 1 (6)
P 2 (4)
P 3 (1)
P 4 (2)

Trial Status

Completed20
Recruiting7
Unknown4
Not Yet Recruiting2
Terminated1

Trial Success Rate

95.2%

Benchmark: 86.5%

Based on 20 completed trials

Clinical Trials (34)

Showing 20 of 20 trials
NCT07569172Not ApplicableNot Yet Recruiting

Improved Child Nutrition and Development Through Social Transfers

NCT06877923Not ApplicableRecruiting

Elemental 028 Extra Case Studies

NCT07059091Phase 2Recruiting

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

NCT05119868Not ApplicableRecruitingPrimary

Effects of the Mediterranean Diet During Pregnancy on the Onset of Allergies in the Offspring

NCT06943534Phase 2RecruitingPrimary

Omalizumab Weight-Based Dosing Efficacy Trial

NCT06002685Not ApplicableRecruiting

Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention

NCT07209774Not Yet Recruiting

Healthspan Connect Programme of Research

NCT06771791Phase 3RecruitingPrimary

Evaluation of the Efficacy of Oral Immunotherapy with Raw Apple in Patients Allergic to Birch Pollen and Apple: Prospective, Multicenter, Comparative Phase III Study

NCT04644783Not ApplicableCompleted

Novel Blood Test to Predict Safe Foods for Infants and Toddlers With Food Protein-induced Enterocolitis Syndrome (FPIES)

NCT05635266Recruiting

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

NCT03213184Completed

Children's Respiratory and Environmental Workgroup

NCT05473325Unknown

Benchtop NMR Spectroscopy for Assessment of Clinical Human Pathologies (BRANCH-P STUDY)

NCT04641000Terminated

The Alberta BLOOM Long Term Follow Up Study

NCT00779116Phase 4CompletedPrimary

Multi-center, Pediatric, Open-label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec 5.0 mg Chewable Tablet Medications (Study P04574)(COMPLETED)

NCT00780403Phase 4CompletedPrimary

Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed)

NCT01613885CompletedPrimary

Understanding and Diagnosing Allergic Disease in Twins

NCT03106493Completed

Upstate New York Infant Development Screening Program

NCT00426634Completed

Children With Asthma in New Orleans After Hurricane Katrina

NCT02688478Not ApplicableUnknownPrimary

The Phthalate-Allergen Immune Response Study

NCT01792232Not ApplicableCompletedPrimary

Effects of Co-Exposure to Air Pollution and Allergen

Scroll to load more

Research Network

Activity Timeline